CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-08 | Patel Nilay Dahyabhai CLO and CCO | Grant or award · Stock Option (right to Buy) | +30,000 | 30,000 | ||
| 2025-07-07 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +51,500 | 51,500 | ||
| 2025-07-07 | Schaffer Shane J. Chief Executive Officer | Grant or award · Stock Option (right to Buy) | +199,500 | 199,500 | ||
| 2025-07-07 | Myers Laurie EVP and COO | Grant or award · Stock Option (right to Buy) | +31,000 | 31,000 | ||
| 2025-07-07 | Callahan Jennifer L. SVP and CFO | Grant or award · Stock Option (right to Buy) | +64,500 | 64,500 | ||
| 2025-07-07 | Brams Matthew EVP and Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +52,500 | 52,500 | ||
| 2025-06-30 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +1,000 | 1,000 | ||
| 2025-06-20 | Werth Peter J. Director | Grant or award · Stock Option (right to Buy) | +15,000 | 15,000 | ||
| 2025-06-20 | ROBERTS JOHN A Director | Grant or award · Stock Option (right to Buy) | +15,000 | 15,000 | ||
| 2025-06-20 | Lawrence Bryan Jay Director | Grant or award · Stock Option (right to Buy) | +15,000 | 15,000 | ||
| 2025-06-20 | Ervin Jeffrey S Director | Grant or award · Stock Option (right to Buy) | +15,000 | 15,000 | ||
| 2025-03-31 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +1,000 | 1,000 | ||
| 2025-02-18 | Callahan Jennifer L. SVP and CFO | Grant or award · Stock Option (right to Buy) | +21,140 | 21,140 | ||
| 2025-02-18 | Schaffer Shane J. Chief Executive Officer | Grant or award · Stock Option (right to Buy) | +70,489 | 70,489 | ||
| 2025-02-18 | Myers Laurie EVP and COO | Grant or award · Stock Option (right to Buy) | +17,630 | 17,630 | ||
| 2025-02-18 | Brams Matthew EVP and Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +17,630 | 17,630 | ||
| 2025-02-18 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +17,630 | 17,630 | ||
| 2025-01-17 | Callahan Jennifer L. SVP and CFO | Grant or award · Stock Option (right to Buy) | +11,539 | 11,539 | ||
| 2025-01-17 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +2,748 | 2,748 | ||
| 2025-01-17 | Myers Laurie EVP and COO | Grant or award · Stock Option (right to Buy) | +9,319 | 9,319 |
Page 3 of 11 · 202 trades